Home

aynısı kişiselleştirilmiş Yasaya göre puma cell signaling ifade vermek zebra Laleler

Proposed model for PUMA-mediated apoptosis. PUMA (P53 upregulated... |  Download Scientific Diagram
Proposed model for PUMA-mediated apoptosis. PUMA (P53 upregulated... | Download Scientific Diagram

Puma (D30C10) Rabbit mAb | Cell Signaling Technology
Puma (D30C10) Rabbit mAb | Cell Signaling Technology

Cell Death Pathways | Cell Signaling Technology
Cell Death Pathways | Cell Signaling Technology

Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem  cell leukemia/lymphoma syndrome | Cell Death & Disease
Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome | Cell Death & Disease

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of  Breast Cancer | PLOS ONE
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer | PLOS ONE

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of  Breast Cancer | PLOS ONE
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer | PLOS ONE

PUMA Dissociates Bax and Bcl-XL to Induce Apoptosis in Colon Cancer Cells*  - Journal of Biological Chemistry
PUMA Dissociates Bax and Bcl-XL to Induce Apoptosis in Colon Cancer Cells* - Journal of Biological Chemistry

Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell  lines: novel regulation of PUMA - Keuling - 2010 - Pigment Cell &  Melanoma Research - Wiley Online Library
Inhibition of p38 MAPK enhances ABT‐737‐induced cell death in melanoma cell lines: novel regulation of PUMA - Keuling - 2010 - Pigment Cell & Melanoma Research - Wiley Online Library

THE INTERSECTION BETWEEN DNA DAMAGE RESPONSE AND CELL DEATH PATHWAYS |  Experimental oncology
THE INTERSECTION BETWEEN DNA DAMAGE RESPONSE AND CELL DEATH PATHWAYS | Experimental oncology

Puma Antibody (Rodent Specific) | Cell Signaling Technology
Puma Antibody (Rodent Specific) | Cell Signaling Technology

PUMA mediates ER stress-induced apoptosis in portal hypertensive  gastropathy | Cell Death & Disease
PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy | Cell Death & Disease

Puma Antibody | Cell Signaling Technology
Puma Antibody | Cell Signaling Technology

Puma (D30C10) Rabbit mAb | Cell Signaling Technology
Puma (D30C10) Rabbit mAb | Cell Signaling Technology

Puma (D30C10) Rabbit mAb | Cell Signaling Technology
Puma (D30C10) Rabbit mAb | Cell Signaling Technology

Anti-PUMA antibody (ab9643) | Abcam
Anti-PUMA antibody (ab9643) | Abcam

Puma (E2P7G) Rabbit mAb | Cell Signaling Technology
Puma (E2P7G) Rabbit mAb | Cell Signaling Technology

Puma (D30C10) Rabbit mAb | Cell Signaling Technology
Puma (D30C10) Rabbit mAb | Cell Signaling Technology

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of  Breast Cancer | PLOS ONE
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer | PLOS ONE

PUMA Antibody (NB100-56370): Novus Biologicals
PUMA Antibody (NB100-56370): Novus Biologicals

Puma (E2P7G) Rabbit mAb | Cell Signaling Technology
Puma (E2P7G) Rabbit mAb | Cell Signaling Technology

Puma (D30C10) Rabbit mAb | Cell Signaling Technology
Puma (D30C10) Rabbit mAb | Cell Signaling Technology

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of  Breast Cancer | PLOS ONE
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer | PLOS ONE

Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem  cell leukemia/lymphoma syndrome | Cell Death & Disease
Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome | Cell Death & Disease

Anti-PUMA antibody (ab9643) | Abcam
Anti-PUMA antibody (ab9643) | Abcam

The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian  development, cardiovascular and neurodegenerative diseases | SpringerLink
The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases | SpringerLink